Jennifer Roth
Director, PRISM
Broad Institute of MIT and Harvard
Biomedical and cancer discovery, PRISM platform, multiplexed high-throughput chemical screening, CRISPR
Automation, AI, and High-Throughput Methodologies
Time until symposium
The 28th EMBL PhD Symposium explores how automation, high-throughput methodologies, and artificial intelligence are accelerating scientific discovery — enhancing speed, reliability, and reproducibility across biological disciplines.
Over three focused days, we bring together researchers and engineers at the frontier of scalable science: from robotic wet-lab workflows and large-scale screening to AI-driven data analysis and translational biomedical applications.
12
Invited Speakers
3
Focused Days
100+
Participants
Early-Bird Registration Deadline
August 10, 2026
Abstract Submission Deadline
August 26, 2026
Abstract Selection Notification
September 16, 2026
On-Site Registration Deadline
October 21, 2026
Virtual Registration Deadline
November 25, 2026
Symposium Begins
December 2, 2026
Symposium Ends
December 4, 2026
Set in the wooded hills above Heidelberg, EMBL's main campus is home to world-class research facilities and a vibrant international community. The ATC Auditorium seats 500 and provides state-of-the-art conference facilities.
→ Meyerhofstraße 1, 69117 Heidelberg
→ 15 min from Heidelberg city centre
→ On-campus accommodation available
The 28th EMBL PhD Symposium is made possible by the generous support of our institutional and industry partners.
Sponsorship opportunity available. Contact us to learn more about partnership benefits.
EMBL is Europe's flagship laboratory for the life sciences, with facilities and operations across six sites in six member states, and over 1,800 staff and students.
Founder Partners
Corporate Partners
Associate Partners
Contact us to discuss partnership opportunities for the symposium.